ARCHIVES

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

May 9, 1997

SWOG Plans Increase in Payments to Centers for Trial Accrual.

May 25, 2007

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003